Zurich Cantonal Bank
CBIO

Zurich Cantonal Bank’s Crescent Biopharma CBIO Stock Holding History

Zurich Cantonal Bank’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-20
Closed -$8K – 2604
2019
Q3 		$8K Hold
20
– – ﹤0.01% 2567
2019
Q2 		$24K Hold
20
– – ﹤0.01% 2414
2019
Q1 		$25K Sell
20
-17
-46% -$19.5K ﹤0.01% 2345
2018
Q4 		$35K Hold
37
– – ﹤0.01% 2226
2018
Q3 		$53K Buy
37
+13
+54% +$19.7K ﹤0.01% 2125
2018
Q2 		$39K Buy
+24
New +$41.3K ﹤0.01% 2259

Other funds holding CBIO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $718M AUM 8.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return